» Articles » PMID: 27956899

Body Composition in Adult Patients with Thalassemia Major

Overview
Publisher Wiley
Specialty Endocrinology
Date 2016 Dec 14
PMID 27956899
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

. To assess body composition in adult male and female patients with thalassemia major by dual-energy X-ray absorptiometry (DXA) and to compare the findings with a group of healthy age-matched controls. . Our study group included sixty-two patients (27 males, mean age 36 years, and 35 females, mean age 36.4 years) and fifteen age-matched healthy controls. All patients had an established diagnosis of thalassemia major and followed a regular blood transfusion scheme since childhood and chelation treatment. Fat, lean, and bone mineral density (BMD) were assessed with dual-energy X-ray absorptiometry. Ferritin levels and body mass index of all patients and controls were also recorded. Student test and Wilcoxon test were performed and statistical significance was set at < 0.05. . BMD and whole body lean mass are lower in both male and female adult patients compared with controls ( < 0.01 in both groups), whereas whole body fat mass was found to have no statistically significant difference compared to controls. Regional trunk fat around the abdomen was found to be lower in male patients compared to controls ( = 0.02). . Severe bone loss and diminished lean mass are expected in adult male and female patients with thalassemia major. Fat changes seem to affect mainly male patients.

Citing Articles

Nutritional studies in patients with β-thalassemia major: A short review.

Soliman A, Yassin M, Alyafei F, Alaaraj N, Hamed N, Osman S Acta Biomed. 2023; 94(3):e2023187.

PMID: 37326258 PMC: 10308461. DOI: 10.23750/abm.v94i3.14732.


Nutritional Status in a Sample of Patients With β-Thalassemia Major.

Lidoriki I, Stavrou G, Schizas D, Frountzas M, Fotis L, Kapelouzou A Cureus. 2022; 14(8):e27985.

PMID: 36120275 PMC: 9468758. DOI: 10.7759/cureus.27985.


Correlation between Serum Fatty Acid Binding Protein 4 (FABP4) Levels and Cardiac Function in Patients with Thalassemia Major.

Fianza P, Rahmawati A, Afifah S, Praptama S, Ghozali M, Sihite T Dis Markers. 2022; 2021:5130628.

PMID: 34987673 PMC: 8723846. DOI: 10.1155/2021/5130628.


Investigating the Role of Ferritin in Determining Sexual Underdevelopment in Beta-Thalassemia Major Patients: A Cross-Sectional Analysis From Pakistan.

Shahid Z, Hassan S, Ghazanfar S, Kaneez M, Khan M, Tariq H Cureus. 2021; 13(6):e15572.

PMID: 34277194 PMC: 8270070. DOI: 10.7759/cureus.15572.

References
1.
Gamberini M, De Sanctis V, Gilli G . Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev. 2009; 6 Suppl 1:158-69. View

2.
Triantafyllou A, Vyssoulis G, Karpanou E, Karkalousos P, Triantafyllou E, Aessopos A . Impact of β-thalassemia trait carrier state on cardiovascular risk factors and metabolic profile in patients with newly diagnosed hypertension. J Hum Hypertens. 2013; 28(5):328-32. DOI: 10.1038/jhh.2013.102. View

3.
Kendler D, Borges J, Fielding R, Itabashi A, Krueger D, Mulligan K . The Official Positions of the International Society for Clinical Densitometry: Indications of Use and Reporting of DXA for Body Composition. J Clin Densitom. 2013; 16(4):496-507. DOI: 10.1016/j.jocd.2013.08.020. View

4.
Saki N, Abroun S, Salari F, Rahim F, Shahjahani M, Javad M . Molecular Aspects of Bone Resorption in β-Thalassemia Major. Cell J. 2015; 17(2):193-200. PMC: 4503833. DOI: 10.22074/cellj.2016.3713. View

5.
Kalef-Ezra J, Zibis A, Chaliassos N, Hatzikonstantinou I, Karantanas A . Body composition in homozygous beta-thalassemia. Ann N Y Acad Sci. 2000; 904:621-4. DOI: 10.1111/j.1749-6632.2000.tb06527.x. View